Question 1

Has Punit Wadhwa, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $51 in general payments to Punit Wadhwa, MD across 3 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Punit Wadhwa, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Punit Wadhwa, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	2	$39
Gilead	1	$12

Drug	Claims	Cost to plans & patients
IbrancePalbociclib	51	$827,436
BrukinsaZanubrutinib	33	$484,664
JakafiRuxolitinib Phosphate	24	$433,964
NubeqaDarolutamide	27	$364,620
Lenalidomide	22	$334,622
XtandiEnzalutamide	16	$214,483
EliquisApixaban	27	$22,583
Abiraterone Acetate	36	$10,569
Anastrozole	152	$3,833
Letrozole	54	$1,644
Tamoxifen Citrate	37	$1,402
Hydroxyurea	57	$1,319
Dexamethasone	67	$1,096
Prochlorperazine Maleate	51	$1,015
Gabapentin	37	$443

Punit Wadhwa, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other hematology & oncology in St Louis Park